CStone Pharmaceuticals and Blueprint Medicines Initiate Phase 1b/2 Trial
06 Jan 2020 //
PR NEWSWIRE
Blueprint Medicines Announces Updated Data from Pha1 EXPLORER CTRLof Avapritinib
15 Jun 2018 //
PRESS RELEASE
Blueprint Medicines Initiates VOYAGER Ph3 Clinical Trial of Avapritinib
21 May 2018 //
PRESS RELEASE